Trial results show longer progression-free survival with sunitinib and everolimus

Wednesday, February 9, 2011 (Last Updated: 02/10/2011)

platelet-derived growth factor receptor

Specialties Hematology & Oncology
Gastroenterology
Diabetes & Endocrinology
Neurology
Pharmacy

Copyright © 2011 HealthDay. All rights reserved.